| Sarba Kundu, MD | |
|
201 W Main St, Elkin, NC 28621-3490 | |
| (336) 526-6195 | |
| (336) 527-8379 |
| Full Name | Sarba Kundu |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 24 Years |
| Location | 201 W Main St, Elkin, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407838014 | NPI | - | NPPES |
| 7338732 | Other | NC | AETNA |
| 3810003047 | Medicaid | WV | |
| E4472 | Other | NC | MEDCOST |
| 10179505 | Medicaid | VA | |
| 806756 | Other | NC | PARTNERS |
| 139XG | Other | NC | BCBS |
| 5902129 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 2005-01105 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hugh Chatham Memorial Hospital | Elkin, NC | Hospital |
| North Carolina Baptist Hospital | Winston-salem, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hugh Chatham Memorial Hospital Inc | 2062311442 | 87 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved the first naloxone treatment specifically designed to be given by family members or caregivers to treat a person with opioid overdose.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
BusinessWeek: "With Congress' sweeping overhaul of the health system stalled, industry will seek its own answers to a push by government and the private sector to rein in costs, said Curtis Lane, senior managing director at MTS Health Partners, a New York-based equity fund."
Progress made in the technology development for studying protein-DNA interactions, conducted by Chang Lu, associate professor of chemical engineering and a core faculty member of the School of Biomedical Engineering and Sciences at Virginia Tech, has led to the National Institutes of Health (NIH) awarding a new project to continue his groundbreaking work.
Laboratory Corporation of America Holdings announced today the launch of an innovative age-based test protocol that aids physicians when ordering cervical cancer and sexually transmitted disease (STD) screening tests.
› Verified 4 days ago
| Entity Name | Hugh Chatham Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447373063 PECOS PAC ID: 2062311442 Enrollment ID: O20040717000340 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved the first naloxone treatment specifically designed to be given by family members or caregivers to treat a person with opioid overdose.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
BusinessWeek: "With Congress' sweeping overhaul of the health system stalled, industry will seek its own answers to a push by government and the private sector to rein in costs, said Curtis Lane, senior managing director at MTS Health Partners, a New York-based equity fund."
Progress made in the technology development for studying protein-DNA interactions, conducted by Chang Lu, associate professor of chemical engineering and a core faculty member of the School of Biomedical Engineering and Sciences at Virginia Tech, has led to the National Institutes of Health (NIH) awarding a new project to continue his groundbreaking work.
Laboratory Corporation of America Holdings announced today the launch of an innovative age-based test protocol that aids physicians when ordering cervical cancer and sexually transmitted disease (STD) screening tests.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarba Kundu, MD 201 W Main St, Elkin, NC 28621-3490 Ph: (336) 526-6195 | Sarba Kundu, MD 201 W Main St, Elkin, NC 28621-3490 Ph: (336) 526-6195 |
News Archive
The U.S. Food and Drug Administration (FDA) has approved the first naloxone treatment specifically designed to be given by family members or caregivers to treat a person with opioid overdose.
StemCells, Inc. (NASDAQ:STEM) announced today that it will soon initiate with the University of California, San Francisco (UCSF) Children's Hospital a Phase I clinical trial to evaluate the therapeutic potential of StemCells' proprietary HuCNS-SC® product candidate (purified human neural stem cells) to treat Pelizaeus-Merzbacher Disease (PMD), a myelination disorder that primarily affects infants and young children.
BusinessWeek: "With Congress' sweeping overhaul of the health system stalled, industry will seek its own answers to a push by government and the private sector to rein in costs, said Curtis Lane, senior managing director at MTS Health Partners, a New York-based equity fund."
Progress made in the technology development for studying protein-DNA interactions, conducted by Chang Lu, associate professor of chemical engineering and a core faculty member of the School of Biomedical Engineering and Sciences at Virginia Tech, has led to the National Institutes of Health (NIH) awarding a new project to continue his groundbreaking work.
Laboratory Corporation of America Holdings announced today the launch of an innovative age-based test protocol that aids physicians when ordering cervical cancer and sexually transmitted disease (STD) screening tests.
› Verified 4 days ago
Philip James Iuliano, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 189 Samaritans Ridge Rd, Elkin, NC 28621 Phone: 336-526-3005 Fax: 336-526-3011 | |
Dr. Dennis J Bauman, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 380 Parkwood Medical Park, Elkin, NC 28621 Phone: 336-835-9355 Fax: 336-835-8581 | |
Dr. Saiyyed Oomer Aziem, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 Johnson Ridge Medical Park, Elkin, NC 28621 Phone: 336-526-3005 Fax: 336-526-3011 | |
Dr. Jeannette A. Loman, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 180 Parkwood Drive, Elkin, NC 28621 Phone: 336-527-7463 Fax: 336-527-7189 | |
Paul Hudson Gulley, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 500 Chatham Medical Park, Elkin, NC 28621 Phone: 336-835-3136 Fax: 336-835-6038 | |
Paul Leslie Garrison Jr., MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 500 Chatham Medical Park, Elkin, NC 28621 Phone: 336-835-3136 Fax: 336-835-6038 | |
Kenneth Raynor Gallup Jr., MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 Chatham Medical Park, Elkin, NC 28621 Phone: 336-527-7198 Fax: 336-527-8379 |